Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Capricor Therapeutics (CAPR) Times Interest Earned (2016 - 2017)

Historic Times Interest Earned for Capricor Therapeutics (CAPR) over the last 9 years, with Q4 2017 value amounting to -$40.85.

  • Capricor Therapeutics' Times Interest Earned fell 4428.57% to -$40.85 in Q4 2017 from the same period last year, while for Sep 2018 it was -$190.54, marking a year-over-year decrease of 54259.12%. This contributed to the annual value of -$32.25 for FY2017, which is 3452.01% up from last year.
  • As of Q4 2017, Capricor Therapeutics' Times Interest Earned stood at -$40.85, which was down 4428.57% from -$24.5 recorded in Q3 2017.
  • Over the past 5 years, Capricor Therapeutics' Times Interest Earned peaked at -$24.5 during Q3 2017, and registered a low of -$385.96 during Q1 2013.
  • Over the past 5 years, Capricor Therapeutics' median Times Interest Earned value was -$48.22 (recorded in 2014), while the average stood at -$74.87.
  • As far as peak fluctuations go, Capricor Therapeutics' Times Interest Earned soared by 8959.3% in 2014, and later tumbled by 8699.51% in 2015.
  • Capricor Therapeutics' Times Interest Earned (Quarter) stood at -$63.98 in 2013, then skyrocketed by 61.37% to -$24.71 in 2014, then crashed by 109.04% to -$51.66 in 2015, then soared by 45.2% to -$28.31 in 2016, then crashed by 44.29% to -$40.85 in 2017.
  • Its Times Interest Earned was -$40.85 in Q4 2017, compared to -$24.5 in Q3 2017 and -$32.02 in Q2 2017.